TELA Bio (TELA) Share-based Compensation (2018 - 2026)

TELA Bio's Share-based Compensation history runs 9 years deep, the most recent figure standing at $816000.0 for Q1 2026.

• In Q1 2026, Share-based Compensation fell 21.84% year-over-year to $816000.0; the TTM figure through Mar 2026 stood at $3.6 million (down 17.1% YoY), while the FY2025 annual figure was $3.8 million, down 12.98% from the prior year.
• Share-based Compensation was $816000.0 for Q1 2026 at TELA Bio, roughly flat from $812000.0 in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $1.4 million in Q3 2023 to a low of $812000.0 in Q4 2025.
• Historically, Share-based Compensation has averaged $1.1 million across 5 years, with a median of $1.0 million in 2025.
• Biggest YoY gain for Share-based Compensation was 40.11% in 2022; the steepest drop was 27.62% in 2022.
• A 5-year view of Share-based Compensation shows it stood at $1.0 million in 2022, then advanced by 19.44% to $1.2 million in 2023, then declined by 12.25% to $1.1 million in 2024, then fell by 25.44% to $812000.0 in 2025, then climbed by 0.49% to $816000.0 in 2026.
• The last three Share-based Compensation figures came in at $816000.0 (Q1 2026), $812000.0 (Q4 2025), and $955000.0 (Q3 2025), per Business Quant data.